StemCardia
PrivateCompany Overview
StemCardia is a biotechnology company that develops cellular and genetic therapies to address heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
cell therapyregenerative medicineheart failure therapycardiac repairinduced pluripotent stem cellsiPSCcardiomyocyte therapyoff-the-shelf cell therapystem cell therapycardiac remuscularizationallogeneic cell therapyregen medcardiac gene therapyclinical-stage biotechbiotherapeutic delivery
Historical Pricing
Historical view of private secondary pricing and transaction trends.
StemCardia Comparables
Compare StemCardia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heartseed | 86% | |
| Help Therapeutics | 85% | |
| BioCardia Inc | 74% | |
StemCardia Funding Rounds
Historical fundraising activity
StemCardia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about StemCardia's valuation, stock price, and market status.